Oxford BioMedica licences technology for cystic fibrosis treatment Read More
IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares Read More
LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear Read More
TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group Read More
LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut Read More
UPDATE: Oxford Nanopore nears GBP5 billion value in London debut Read More
TOP NEWS: Oxford Nanopore hits GBP4.6 billion value in London debut Read More
UK dividends calendar - next 7 days Read More
LONDON MARKET CLOSE: Stocks up; airlines fly higher on sector optimism Read More
TOP NEWS: Oxford Nanopore signs up Oracle as IPO cornerstone investor Read More
LONDON BRIEFING: Oxford Nanopore has Oracle as investor for London IPO Read More
LONDON MARKET PRE-OPEN: Ashtead lifts outlook; Ryanair plots growth Read More
LONDON MARKET CLOSE: Stocks fall as China factory gate inflation jumps Read More
Oxford Nanopore planning float on London's Main Market Read More
LONDON MARKET CLOSE: Strong start to September on risk appetite return Read More
PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters Read More
IP Group plots maiden buyback as makes "strong headway" in first half Read More
UK earnings, trading statements calendar - next 7 days Read More
IP Group's Artios raises USD153 million for cancer therapy pipeline Read More
